Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Postnatal development of the astrocyte perivascular MLC1/GlialCAM complex defines a temporal window for the gliovascular unit maturation.

Gilbert A, Vidal XE, Estevez R, Cohen-Salmon M, Boulay AC.

Brain Struct Funct. 2019 Apr;224(3):1267-1278. doi: 10.1007/s00429-019-01832-w. Epub 2019 Jan 25.

PMID:
30684007
2.

Preparing the Astrocyte Perivascular Endfeet Transcriptome to Investigate Astrocyte Molecular Regulations at the Brain-Vascular Interface.

Boulay AC, Mazaré N, Saubaméa B, Cohen-Salmon M.

Methods Mol Biol. 2019;1938:105-116. doi: 10.1007/978-1-4939-9068-9_8.

PMID:
30617976
3.

RanBP2 regulates the anti-retroviral activity of TRIM5α by SUMOylation at a predicted phosphorylated SUMOylation motif.

Maarifi G, Fernandez J, Portilho DM, Boulay A, Dutrieux J, Oddos S, Butler-Browne G, Nisole S, Arhel NJ.

Commun Biol. 2018 Nov 15;1:193. doi: 10.1038/s42003-018-0198-0. eCollection 2018.

4.

Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain.

Chasseigneaux S, Moraca Y, Cochois-Guégan V, Boulay AC, Gilbert A, Le Crom S, Blugeon C, Firmo C, Cisternino S, Laplanche JL, Curis E, Declèves X, Saubaméa B.

Sci Rep. 2018 Aug 16;8(1):12272. doi: 10.1038/s41598-018-30739-5.

5.

Connexin 43 Controls the Astrocyte Immunoregulatory Phenotype.

Boulay AC, Gilbert A, Oliveira Moreira V, Blugeon C, Perrin S, Pouch J, Le Crom S, Ducos B, Cohen-Salmon M.

Brain Sci. 2018 Mar 22;8(4). pii: E50. doi: 10.3390/brainsci8040050.

6.

A Multimedia Hydrological Fate Modeling Framework To Assess Water Consumption Impacts in Life Cycle Assessment.

Núñez M, Rosenbaum RK, Karimpour S, Boulay AM, Lathuillière MJ, Margni M, Scherer L, Verones F, Pfister S.

Environ Sci Technol. 2018 Apr 17;52(8):4658-4667. doi: 10.1021/acs.est.7b05207. Epub 2018 Mar 30.

PMID:
29565125
7.

Connexin 30 is expressed in a subtype of mouse brain pericytes.

Mazaré N, Gilbert A, Boulay AC, Rouach N, Cohen-Salmon M.

Brain Struct Funct. 2018 Mar;223(2):1017-1024. doi: 10.1007/s00429-017-1562-4. Epub 2017 Nov 16.

PMID:
29143947
8.

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy.

Sicre de Fontbrune F, Arnaud C, Cheminant M, Boulay A, Konopacki J, Lapusan S, Robin C, Bernaudin F, Suarez F, Simon F, Socié G, Colin de Verdière N, Consigny PH.

J Infect Dis. 2018 Jan 17;217(3):494-497. doi: 10.1093/infdis/jix564.

PMID:
29087520
9.

Translation in astrocyte distal processes sets molecular heterogeneity at the gliovascular interface.

Boulay AC, Saubaméa B, Adam N, Chasseigneaux S, Mazaré N, Gilbert A, Bahin M, Bastianelli L, Blugeon C, Perrin S, Pouch J, Ducos B, Le Crom S, Genovesio A, Chrétien F, Declèves X, Laplanche JL, Cohen-Salmon M.

Cell Discov. 2017 Mar 28;3:17005. doi: 10.1038/celldisc.2017.5. eCollection 2017.

10.

Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration.

Chakravarthy U, Bailey C, Brown D, Campochiaro P, Chittum M, Csaky K, Tufail A, Yates P, Cech P, Giraudon M, Delmar P, Szczesny P, Sahni J, Boulay A, Nagel S, Fürst-Recktenwald S, Schwab D.

Ophthalmol Retina. 2017 Nov - Dec;1(6):474-485. doi: 10.1016/j.oret.2017.03.003. Epub 2017 May 23.

PMID:
31047438
11.

Understanding the LCA and ISO water footprint: A response to Hoekstra (2016) "A critique on the water-scarcity weighted water footprint in LCA".

Pfister S, Boulay AM, Berger M, Hadjikakou M, Motoshita M, Hess T, Ridoutt B, Weinzettel J, Scherer L, Döll P, Manzardo A, Núñez M, Verones F, Humbert S, Buxmann K, Harding K, Benini L, Oki T, Finkbeiner M, Henderson A.

Ecol Indic. 2017 Jan;72:352-359. doi: 10.1016/j.ecolind.2016.07.051.

12.

Optical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.

Leygue N, Boulay A, Galaup C, Benoist E, Laurent S, Vander Elst L, Mestre-Voegtlé B, Picard C.

Dalton Trans. 2016 May 17;45(20):8379-93. doi: 10.1039/c6dt00405a.

PMID:
27109253
13.

Endogenous TRIM5α Function Is Regulated by SUMOylation and Nuclear Sequestration for Efficient Innate Sensing in Dendritic Cells.

Portilho DM, Fernandez J, Ringeard M, Machado AK, Boulay A, Mayer M, Müller-Trutwin M, Beignon AS, Kirchhoff F, Nisole S, Arhel NJ.

Cell Rep. 2016 Jan 12;14(2):355-69. doi: 10.1016/j.celrep.2015.12.039. Epub 2015 Dec 31.

14.

Immunoregulation at the gliovascular unit in the healthy brain: A focus on Connexin 43.

Boulay AC, Cisternino S, Cohen-Salmon M.

Brain Behav Immun. 2016 Aug;56:1-9. doi: 10.1016/j.bbi.2015.11.017. Epub 2015 Dec 7. Review.

PMID:
26674996
15.

Purification of Mouse Brain Vessels.

Boulay AC, Saubaméa B, Declèves X, Cohen-Salmon M.

J Vis Exp. 2015 Nov 10;(105):e53208. doi: 10.3791/53208.

16.

Immune quiescence of the brain is set by astroglial connexin 43.

Boulay AC, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, Blugeon C, Mignon V, Smirnova M, Cavallo A, Ezan P, Avé P, Dingli F, Loew D, Vieira P, Chrétien F, Cohen-Salmon M.

J Neurosci. 2015 Mar 11;35(10):4427-39. doi: 10.1523/JNEUROSCI.2575-14.2015.

17.

The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels.

Boulay AC, Saubaméa B, Cisternino S, Mignon V, Mazeraud A, Jourdren L, Blugeon C, Cohen-Salmon M.

Front Cell Neurosci. 2015 Feb 2;9:9. doi: 10.3389/fncel.2015.00009. eCollection 2015.

18.

Making sense of the minefield of footprint indicators.

Ridoutt B, Fantke P, Pfister S, Bare J, Boulay AM, Cherubini F, Frischknecht R, Hauschild M, Hellweg S, Henderson A, Jolliet O, Levasseur A, Margni M, McKone T, Michelsen O, Milà i Canals L, Page G, Pant R, Raugei M, Sala S, Saouter E, Verones F, Wiedmann T.

Environ Sci Technol. 2015 Mar 3;49(5):2601-3. doi: 10.1021/acs.est.5b00163. Epub 2015 Feb 12. No abstract available.

PMID:
25675252
19.

Terpyridine-based heteroditopic ligand for Ru(II)Ln3(III) metallostar architectures (Ln = Gd, Eu, Nd, Yb) with MRI/optical or dual-optical responses.

Boulay A, Deraeve C, Vander Elst L, Leygue N, Maury O, Laurent S, Muller RN, Mestre-Voegtlé B, Picard C.

Inorg Chem. 2015 Feb 16;54(4):1414-25. doi: 10.1021/ic502342x. Epub 2015 Jan 16.

PMID:
25594876
20.

Characteristics of the peanut chain in Europe - implications for peanut allergy.

Prusak A, Schlegel-Zawadzka M, Boulay A, Rowe G.

Acta Sci Pol Technol Aliment. 2014 Jul-Sep;13(3):321-33.

PMID:
24887947
21.

Tracking "apolar" NMe4+ ions within two polyoxothiomolybdates that have the same pores: smaller clathrate and larger highly porous clusters in action.

Korenev VS, Boulay AG, Haouas M, Bannani F, Fedin VP, Sokolov MN, Terazzi E, Garai S, Müller A, Taulelle F, Marrot J, Leclerc N, Floquet S, Cadot E.

Chemistry. 2014 Mar 10;20(11):3097-105. doi: 10.1002/chem.201303719. Epub 2014 Feb 12.

PMID:
24519761
22.

Complementarities of water-focused life cycle assessment and water footprint assessment.

Boulay AM, Hoekstra AY, Vionnet S.

Environ Sci Technol. 2013;47(21):11926-7. doi: 10.1021/es403928f. Epub 2013 Oct 22. No abstract available.

PMID:
24147821
23.

A functionalized heterobimetallic (99m)Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations.

François A, Auzanneau C, Le Morvan V, Galaup C, Godfrey HS, Marty L, Boulay A, Artigau M, Mestre-Voegtlé B, Leygue N, Picard C, Coulais Y, Robert J, Benoist E.

Dalton Trans. 2014 Jan 14;43(2):439-50. doi: 10.1039/c3dt51968f.

PMID:
24061542
24.

Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).

Manirakiza A, Sepou A, Serdouma E, Gondje S, Bata GG, Moussa S, Boulay A, Moyen JM, Sakanga O, Le-Fouler L, Kazanji M, Vray M.

Trials. 2013 Aug 14;14:255. doi: 10.1186/1745-6215-14-255.

25.

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.

Gattelli A, Nalvarte I, Boulay A, Roloff TC, Schreiber M, Carragher N, Macleod KK, Schlederer M, Lienhard S, Kenner L, Torres-Arzayus MI, Hynes NE.

EMBO Mol Med. 2013 Sep;5(9):1335-50. doi: 10.1002/emmm.201302625. Epub 2013 Jul 19.

26.

Salt. UK consumers' perceptions and consumption patterns.

Kenten C, Boulay A, Rowe G.

Appetite. 2013 Nov;70:104-11. doi: 10.1016/j.appet.2013.06.095. Epub 2013 Jul 11.

PMID:
23850983
27.

Hearing is normal without connexin30.

Boulay AC, del Castillo FJ, Giraudet F, Hamard G, Giaume C, Petit C, Avan P, Cohen-Salmon M.

J Neurosci. 2013 Jan 9;33(2):430-4. doi: 10.1523/JNEUROSCI.4240-12.2013.

28.

Bmcc1s interacts with the phosphate-activated glutaminase in the brain.

Boulay AC, Burbassi S, Lorenzo HK, Loew D, Ezan P, Giaume C, Cohen-Salmon M.

Biochimie. 2013 Apr;95(4):799-807. doi: 10.1016/j.biochi.2012.11.016. Epub 2012 Dec 12.

PMID:
23246912
29.

A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria.

Coutant F, Sanchez David RY, Félix T, Boulay A, Caleechurn L, Souque P, Thouvenot C, Bourgouin C, Beignon AS, Charneau P.

PLoS One. 2012;7(11):e48644. doi: 10.1371/journal.pone.0048644. Epub 2012 Nov 2.

30.

Bmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions.

Arama J, Boulay AC, Bosc C, Delphin C, Loew D, Rostaing P, Amigou E, Ezan P, Wingertsmann L, Guillaud L, Andrieux A, Giaume C, Cohen-Salmon M.

PLoS One. 2012;7(4):e35488. doi: 10.1371/journal.pone.0035488. Epub 2012 Apr 16.

31.

Morphogenesis of polyoxometalate cluster-based materials to microtubular network architectures.

Boulay AG, Cooper GJ, Cronin L.

Chem Commun (Camb). 2012 May 25;48(42):5088-90. doi: 10.1039/c2cc31194a. Epub 2012 Apr 19.

PMID:
22513869
32.

Deletion of astroglial connexins weakens the blood-brain barrier.

Ezan P, André P, Cisternino S, Saubaméa B, Boulay AC, Doutremer S, Thomas MA, Quenech'du N, Giaume C, Cohen-Salmon M.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1457-67. doi: 10.1038/jcbfm.2012.45. Epub 2012 Apr 4.

33.

Real-time ion-flux imaging in the growth of micrometer-scale structures and membranes.

Nemeth B, Symes MD, Boulay AG, Busche C, Cooper GJ, Cumming DR, Cronin L.

Adv Mater. 2012 Mar 2;24(9):1238-42. doi: 10.1002/adma.201104345. Epub 2012 Jan 30.

PMID:
22290758
34.

Regional characterization of freshwater Use in LCA: modeling direct impacts on human health.

Boulay AM, Bulle C, Bayart JB, Deschênes L, Margni M.

Environ Sci Technol. 2011 Oct 15;45(20):8948-57. doi: 10.1021/es1030883. Epub 2011 Sep 23.

PMID:
21905685
35.

Osmotically driven crystal morphogenesis: a general approach to the fabrication of micrometer-scale tubular architectures based on polyoxometalates.

Cooper GJ, Boulay AG, Kitson PJ, Ritchie C, Richmond CJ, Thiel J, Gabb D, Eadie R, Long DL, Cronin L.

J Am Chem Soc. 2011 Apr 20;133(15):5947-54. doi: 10.1021/ja111011j. Epub 2011 Mar 29.

PMID:
21446750
36.

First dinuclear Re/Tc complex as a potential bimodal Optical/SPECT molecular imaging agent.

Boulay A, Artigau M, Coulais Y, Picard C, Mestre-Voegtlé B, Benoist E.

Dalton Trans. 2011 Jun 21;40(23):6206-9. doi: 10.1039/c0dt01397h. Epub 2011 Mar 18.

PMID:
21416103
37.

A new oxomolybdate component extracted from the "virtual dynamic library" yielding the macrocyclic anion [(Mo(VI)(8)O(28))(4)(Mo(V)(2)O(2)S(2))(4)](24-).

Korenev VS, Boulay AG, Dolbecq A, Sokolov MN, Hijazi A, Floquet S, Fedin VP, Cadot E.

Inorg Chem. 2010 Nov 1;49(21):9740-2. doi: 10.1021/ic101545w.

PMID:
20873799
38.

Copine-III interacts with ErbB2 and promotes tumor cell migration.

Heinrich C, Keller C, Boulay A, Vecchi M, Bianchi M, Sack R, Lienhard S, Duss S, Hofsteenge J, Hynes NE.

Oncogene. 2010 Mar 18;29(11):1598-610. doi: 10.1038/onc.2009.456. Epub 2009 Dec 14.

PMID:
20010870
39.

Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper.

Grimshaw KE, Allen K, Edwards CA, Beyer K, Boulay A, van der Aa LB, Sprikkelman A, Belohlavkova S, Clausen M, Dubakiene R, Duggan E, Reche M, Marino LV, Nørhede P, Ogorodova L, Schoemaker A, Stanczyk-Przyluska A, Szepfalusi Z, Vassilopoulou E, Veehof SH, Vlieg-Boerstra BJ, Wjst M, Dubois AE.

Allergy. 2009 Oct;64(10):1407-16. doi: 10.1111/j.1398-9995.2009.02172.x. Review.

PMID:
19772511
40.

WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.

Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE.

Breast Cancer Res. 2009;11(3):R32. doi: 10.1186/bcr2317. Epub 2009 May 27.

41.

mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.

Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.

Clin Cancer Res. 2009 Mar 1;15(5):1612-22. doi: 10.1158/1078-0432.CCR-08-2057. Epub 2009 Feb 17.

42.

Memo is a cofilin-interacting protein that influences PLCgamma1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration.

Meira M, Masson R, Stagljar I, Lienhard S, Maurer F, Boulay A, Hynes NE.

J Cell Sci. 2009 Mar 15;122(Pt 6):787-97. doi: 10.1242/jcs.032094. Epub 2009 Feb 17.

43.

A EuroPrevall review of factors affecting incidence of peanut allergy: priorities for research and policy.

Boulay A, Houghton J, Gancheva V, Sterk Y, Strada A, Schlegel-Zawadzka M, Sora B, Sala R, van Ree R, Rowe G.

Allergy. 2008 Jul;63(7):797-809. doi: 10.1111/j.1398-9995.2008.01776.x. Review.

PMID:
18588545
44.

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.

Boulay A, Breuleux M, Stephan C, Fux C, Brisken C, Fiche M, Wartmann M, Stumm M, Lane HA, Hynes NE.

Cancer Res. 2008 May 15;68(10):3743-51. doi: 10.1158/0008-5472.CAN-07-5100.

45.

Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data.

Tanaka C, O'Reilly T, Kovarik JM, Shand N, Hazell K, Judson I, Raymond E, Zumstein-Mecker S, Stephan C, Boulay A, Hattenberger M, Thomas G, Lane HA.

J Clin Oncol. 2008 Apr 1;26(10):1596-602. doi: 10.1200/JCO.2007.14.1127. Epub 2008 Mar 10.

PMID:
18332467
46.

The mammalian target of rapamycin kinase and tumor growth inhibition.

Boulay A, Lane HA.

Recent Results Cancer Res. 2007;172:99-124. Review. No abstract available.

PMID:
17607938
47.

The mTOR pathway in breast cancer.

Hynes NE, Boulay A.

J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):53-61. Review.

PMID:
16900391
48.

Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.

Boulay A, Rudloff J, Ye J, Zumstein-Mecker S, O'Reilly T, Evans DB, Chen S, Lane HA.

Clin Cancer Res. 2005 Jul 15;11(14):5319-28.

49.

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

Beuvink I, Boulay A, Fumagalli S, Zilbermann F, Ruetz S, O'Reilly T, Natt F, Hall J, Lane HA, Thomas G.

Cell. 2005 Mar 25;120(6):747-59.

50.

Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases.

Dive V, Andarawewa KL, Boulay A, Matziari M, Beau F, Guerin E, Rousseau B, Yiotakis A, Rio MC.

Int J Cancer. 2005 Feb 20;113(5):775-81.

Supplemental Content

Loading ...
Support Center